Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGOCO.L Regulatory News (GOCO)

  • There is currently no data for GOCO

Form 8 (OPD) GOCO GROUP PLC

3 Dec 2020 07:00

RNS Number : 3495H
Goco Group PLC
03 December 2020
Β 

FORM 8 (OPD)

Β 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a)

Full name of discloser:

GOCO GROUP PLC

(b)

Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c)

Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

GOCO GROUP PLC (OFFEREE)

(d)

Is the discloser the offeror or the offeree?

OFFEREE

(e)

Date position held:

The latest practicable date prior to the disclosure

2 December 2020

(f)

In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

YES

Β 

FUTURE PLC (OFFEROR)

Β 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

Β 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Β 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

Β 

Class of relevant security:

Β 

Ordinary shares of 0.02p each

Β 

Β 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

-

Nil

-

(2) Cash-settled derivatives:

Β 

Nil

-

Nil

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

-

Nil

-

Β 

TOTAL:

Nil

-

Nil

-

Β 

All interests and all short positions should be disclosed.

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental FormΒ 8 (Open Positions).

Β 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

Β 

(b) Rights to subscribe for new securities

Β 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

Β 

Β 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

Β 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

Β 

(A) Interests held by directors of GoCo Group plc and their close relatives and related trusts

Β 

Name

Number of ordinary shares

Percentage of issued ordinary share capital

Sir Peter Wood

125,058,569

29.65%

Matthew Crummack

108,280

0.03%

Alan Burns

23,788

0.01%

Angela Seymour-Jackson

59,915

0.01%

Zillah Byng-Thorne

89,415

0.02%

Joe Hurd and Christina Mireles

28,064

0.01%

Dr Ashley Steel

94,103

0.02%

Adrian Webb

807,745

0.19%

Penelope Webb

232,450

0.06%

Nick Hugh

21,100

0.01%

Β 

Β 

(B) Interests held as options by directors of GoCo Group plc under its share plans

Β 

Name

Share plan

Number of ordinary shares (under option)

Β 

Vesting date

Exercise price (per share) (Β£)

Matthew Crummack

Performance Share Plan (Foundation Award)

Β 

1,028,571

28 February 2021

N/A

Performance Share Plan

Β 

378,021

29 March 2021, 29 March 2022

N/A

714,286

Β 

28 March 2023

N/A

1,344,155

Β 

13 March 2024

N/A

1,478,571

Β 

8 April 2025

Β 

N/A

Deferred Bonus Plan

Β 

23,775

11 April 2021

N/A

73,274

Β 

3 April 2021, 3 April 2022

Β 

N/A

94,017

Β 

8 April 2021, 8 April 2022, 8 April 2023

Β 

N/A

Sharesave Scheme

Β 

27,272

1 October 2022

Β£0.66

Β 

Β 

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Β 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

Β 

4. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

Β 

None

Β 

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Β 

None

Β 

Β 

Β 

(c) Attachments

Β 

Are any Supplemental Forms attached?

Β 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

Β 

Β 

Date of disclosure:

3 December 2020

Contact name:

Nick Edwards, General Counsel and Company Secretary

Telephone number:

01633 654060

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

Β 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
FEEUUOWRRUUURAA
Date   Source Headline
23rd Apr 20191:16 pmRNSNotice of AGM - Correction
12th Apr 20194:08 pmRNSDirector/PDMR Shareholding
8th Apr 20198:22 amRNSAnnual Financial Report and Notice of AGM
4th Apr 20192:06 pmRNSGoCompare.com Group plc - grant of awards
29th Mar 201912:00 pmRNSTotal Voting Rights
20th Mar 20197:00 amRNSGoCompare.com Group plc Capital Markets Day
7th Mar 20195:33 pmRNSDirector/PDMR Shareholding
5th Mar 20195:58 pmRNSHolding(s) in Company
5th Mar 20195:17 pmRNSHolding(s) in Company
5th Mar 20197:00 amRNSDirector/PDMR Shareholding
4th Mar 20199:12 amRNSDirector/PDMR Shareholding
1st Mar 201912:56 pmRNSDirector/PDMR Shareholding
1st Mar 201910:14 amRNSDirector/PDMR Shareholding
28th Feb 20196:17 pmRNSDirector/PDMR Shareholding
28th Feb 20196:16 pmRNSTotal Voting Rights
28th Feb 201911:13 amRNSDirector/PDMR Shareholding
28th Feb 20198:32 amRNSDividend Declaration
28th Feb 20197:00 amRNSGoCompare welcomes Nick Hugh to its Board
28th Feb 20197:00 amRNSGoCompare.com Group plc preliminary results FY 18
20th Feb 20194:37 pmRNSHolding(s) in Company
8th Feb 201910:44 amRNSDirector/PDMR Shareholding
29th Jan 20197:00 amRNSNotice of Preliminary Results
10th Jan 20195:23 pmRNSHolding(s) in Company
10th Jan 20195:20 pmRNSHolding(s) in Company
8th Jan 20194:51 pmRNSDirector/PDMR Shareholding
31st Dec 201811:45 amRNSTotal Voting Rights
31st Dec 201810:02 amRNSBlock listing Interim Review
19th Dec 20187:00 amRNSHolding(s) in Company
18th Dec 201811:50 amRNSHolding(s) in Company
11th Dec 20187:00 amRNSDirector/PDMR Shareholding
30th Nov 20185:21 pmRNSTotal Voting Rights
14th Nov 201811:24 amRNSDirector/PDMR Shareholding
14th Nov 201810:15 amRNSDirector/PDMR Shareholding
12th Nov 20181:10 pmRNSDirector/PDMR Shareholding
9th Nov 20189:31 amRNSDirector/PDMR Shareholding
8th Nov 201811:44 amRNSDirector/PDMR Shareholding
6th Nov 20184:46 pmRNSHolding(s) in Company
5th Nov 20187:00 amRNSGoCompare Group plc to host Capital Markets Day
19th Oct 20183:24 pmRNSHolding(s) in Company
17th Oct 201810:33 amRNSHolding(s) in Company
16th Oct 20185:04 pmRNSHolding(s) in Company
15th Oct 20187:00 amRNSGoCompare launches weflip
10th Oct 201811:40 amRNSDirector/PDMR Shareholding
4th Oct 201811:37 amRNSHolding(s) in Company
3rd Oct 20184:15 pmRNSHolding(s) in Company
3rd Oct 20183:42 pmRNSHolding(s) in Company
2nd Oct 20189:44 amRNSHolding(s) in Company
1st Oct 20182:08 pmRNSHolding(s) in Company
1st Oct 20182:07 pmRNSTotal Voting Rights
13th Sep 201810:28 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.